- Home
- SOAR vs FBIOP Comparison
SOAR vs FBIOP Comparison
Compare SOAR & FBIOP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SOAR
- FBIOP
- Stock Information
- Founded
- SOAR 2021
- FBIOP N/A
- Country
- SOAR United States
- FBIOP United States
- Employees
- SOAR N/A
- FBIOP 101
- Industry
- SOAR Blank Checks
- FBIOP Biotechnology: Pharmaceutical Preparations
- Sector
- SOAR Finance
- FBIOP Health Care
- Exchange
- SOAR Nasdaq
- FBIOP Nasdaq
- Market Cap
- SOAR N/A
- FBIOP N/A
- IPO Year
- SOAR N/A
- FBIOP N/A
- Fundamental
- Price
- SOAR $1.32
- FBIOP $6.93
- Analyst Decision
- SOAR
- FBIOP
- Analyst Count
- SOAR 0
- FBIOP 0
- Target Price
- SOAR N/A
- FBIOP N/A
- AVG Volume (30 Days)
- SOAR 3.0M
- FBIOP N/A
- Earning Date
- SOAR 08-13-2025
- FBIOP N/A
- Dividend Yield
- SOAR N/A
- FBIOP N/A
- EPS Growth
- SOAR N/A
- FBIOP N/A
- EPS
- SOAR N/A
- FBIOP N/A
- Revenue
- SOAR $71,723,000.00
- FBIOP N/A
- Revenue This Year
- SOAR N/A
- FBIOP N/A
- Revenue Next Year
- SOAR N/A
- FBIOP N/A
- P/E Ratio
- SOAR N/A
- FBIOP N/A
- Revenue Growth
- SOAR 259.41
- FBIOP N/A
- 52 Week Low
- SOAR $1.14
- FBIOP N/A
- 52 Week High
- SOAR $19.06
- FBIOP N/A
- Technical
- Relative Strength Index (RSI)
- SOAR 40.55
- FBIOP 36.60
- Support Level
- SOAR $1.55
- FBIOP $6.56
- Resistance Level
- SOAR $2.29
- FBIOP $7.23
- Average True Range (ATR)
- SOAR 0.20
- FBIOP 0.52
- MACD
- SOAR 0.00
- FBIOP -0.09
- Stochastic Oscillator
- SOAR 11.01
- FBIOP 21.08
About FBIOP Fortress Biotech Inc.
Fortress Biotech Inc is a biopharmaceutical company. The firm is involved in the business of acquiring, developing, and commercializing pharmaceutical and biotechnology products. Its product portfolio encompasses Qbrexza, Accutane, Amzeeq, Zilxi, Targadox, Ximino, and Exelderm. The business activities of the group are functioned through Dermatology Product Sales, and Pharmaceutical and Biotechnology Product Development. It derives the majority of its revenues from Dermatology segment. Its subsidiaries also operate in biotechnology, pharmaceutical, oncology and therapeutics sectors.